AUTOLUS THERAPEUTICS PLC - AMERICAN DEPOSITARY SHA
3.1500
14-November-24 09:28:05
15 minutes delayed
Stocks
-0.1400
-4.26%
Today's range
3.1000 - 3.3800
ISIN
N/A
Source
NASDAQ
-
Autolus to hold Annual General Meeting (AGM) of Shareholders on Tuesday, June 28, 2022
31 May 2022 15:01:00 By Nasdaq GlobeNewswire
-
27 May 2022 06:45:51 By Nasdaq GlobeNewswire
-
12 May 2022 09:51:46 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Reports First Quarter 2022 Financial Results and Operational Progress
05 May 2022 06:00:01 By Nasdaq GlobeNewswire
-
02 May 2022 15:31:00 By Nasdaq GlobeNewswire
-
25 Apr 2022 06:01:00 By Nasdaq GlobeNewswire
-
25 Apr 2022 06:00:00 By Nasdaq GlobeNewswire
-
31 Mar 2022 06:00:01 By Nasdaq GlobeNewswire
-
Autolus Therapeutics to Participate in Conferences During April 2022
29 Mar 2022 06:00:01 By Nasdaq GlobeNewswire
-
10 Mar 2022 06:00:02 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Announces Publication Describing Novel Cell Programming Technology
03 Mar 2022 06:00:01 By Nasdaq GlobeNewswire
-
21 Feb 2022 06:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics announces retirement of chief financial officer and succession plan
10 Jan 2022 06:01:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics announces 2022 priorities
10 Jan 2022 06:00:02 By Nasdaq GlobeNewswire
-
Autolus Therapeutics to Present at Conferences During January 2022
05 Jan 2022 06:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics presents positive obe-cel data at the 63rd ASH Annual Meeting & Exposition
13 Dec 2021 06:00:01 By Nasdaq GlobeNewswire
-
06 Dec 2021 06:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics announces the appointment of Dr. William D. Young as a Non-Executive Director
15 Nov 2021 06:00:02 By Nasdaq GlobeNewswire
-
Autolus Therapeutics announces publication describing its small molecule-regulated CAR T cells
10 Nov 2021 06:00:01 By Nasdaq GlobeNewswire
-
08 Nov 2021 01:00:00 By Nasdaq GlobeNewswire